 | Up a level |
Hao, Qiukui; Aertgeerts, Bert; Guyatt, Gordon; Bekkering, Geertruida E; Vandvik, Per Olav; Khan, Safi U; Rodondi, Nicolas; Jackson, Rod; Reny, Jean-Luc; Al Ansary, Lubna; Van Driel, Mieke; Assendelft, Willem J J; Agoritsas, Thomas; Spencer, Frederick; Siemieniuk, Reed A C; Lytvyn, Lyubov; Heen, Anja Fog; Zhao, Qian; Riaz, Irbaz Bin; Ramaekers, Dirk; ... (2022). PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations. BMJ, 377, e069066. BMJ Publishing Group 10.1136/bmj-2021-069066
